MedPath

Application of cultured autologous keratinocytes in combination with a meshed split skin autograft for burn wound healing - Cultured keratinocytes for burn wound treatment

Phase 1
Conditions
Even standard treatment, transplantation with a (meshed) split skin autograft, does not result in satisfactory functional and cosmetic appearance of the healed wound. Due to limited available donor sites meshes needs to be enlarged. Bigger enlargements of meshes give more scarring and mesh pattern are still visible in scars, probably because wound closure still needs several weeks. Application of cultured autologous keratinocytes may enhance wound closure.
MedDRA version: 9.1Level: LLTClassification code 10006795Term: Burns extensive
Registration Number
EUCTR2007-004296-19-NL
Lead Sponsor
Association of Dutch Burn Centres
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

- competent and temporarily incompetent patients 18 years of age or older with acute burn wounds that require widely meshed skin grafting, which do not need immediate excision - minimal study wound area 100 cm2 - maximal study wound area 300 cm2 - maximal TBSA 50% full thickness wounds - Informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Immunocompromised patients - Infected wounds - Use of high doses of (.20mg/pd) corticosteroids and/or cytostatica - Known penicillin allergy - Conditions where the patient is non compliant as judged by a medical specialist

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath